Search results
Found 37925 matches for
The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.
Peijun Zhang
Principal Investigators
Peijun Zhang - Professor of Structural Biology and WELLCOME TRUST INVESTIGATOR
Peter Horby
Clinical Consultants Principal Investigators
FMedSci Peter Horby - Moh Family Foundation Professor of Emerging Infections and Global Health
Peter Ratcliffe
Clinical Consultants Principal Investigators
FRS Peter Ratcliffe - Professor of Clinical Medicine
Anita Milicic
Principal Investigators
Associate Professor Anita Milicic - Group Leader, Vaccine Formulation and Adjuvants
Catherine (Sassy) Molyneux
Principal Investigators
Catherine (Sassy) Molyneux - Professor of Global Health
Rose McGready
Principal Investigators
Rose McGready - Professor of Tropical Maternal and Child Health
Joel Tarning
MSc MGH Lecturers Principal Investigators
Joel Tarning - Professor of Clinical Pharmacology
Louise Thwaites
Clinical Consultants Principal Investigators
BSc MBBS MRCP MD DMSMed MLCOM Louise Thwaites - Associate Professor